IFNA1 and COVID-19: Notably, diminished epithelial antiviral immunity, with delayed IFN production and weakened IFN-induced responses, has been noticed in the nasal mucosa of severely ill COVID-19 patients, suggesting that impaired local IFN responses are involved in uncontrolled viral infection [78, 79].